Last update 21 Nov 2024
Linagliptin/Fimasartan Potassium Trihydrate
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC27H33KN7O2S |
InChIKeyLIVLWNCNPUMSER-UHFFFAOYSA-N |
CAS Registry1020110-23-9 |
View All Structures (2)
Related
1
Clinical Trials associated with Linagliptin/Fimasartan Potassium TrihydrateA Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between a Fixed Dose Combination of Fimasartan 120 mg/Linagliptin 5 mg and Co-administration of Fimasartan 120 mg and Linagliptin 5 mg in Healthy Male Volunteers
100 Clinical Results associated with Linagliptin/Fimasartan Potassium Trihydrate
Login to view more data
100 Translational Medicine associated with Linagliptin/Fimasartan Potassium Trihydrate
Login to view more data
100 Patents (Medical) associated with Linagliptin/Fimasartan Potassium Trihydrate
Login to view more data
100 Deals associated with Linagliptin/Fimasartan Potassium Trihydrate
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus | Phase 1 | KR | 18 Jul 2018 | |
| Hypertension | Phase 1 | KR | 18 Jul 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free